Abbisko and Sperogenix Announce an Exclusive Agreement to Develop ABSK021 for ALS and Other Rare…
Sperogenix MedTech Co., Ltd., a subsidiary of Sperogenix Therapeutics, has entered into an exclusive licensing agreement with Abbisko Therapeutics…